Algeta ASA

Norvège

Commandez votre montre hebdomadaire Algeta ASA
Quantité totale PI 15
Rang # Quantité totale PI 103 185
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 709 712
Parent Bayer Nordic SE
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

2 0
4 1
8 0
0
 
Dernier brevet 2015 - Receptor binding conjugates
Premier brevet 2000 - Receptor binding conjugates
Dernière marque 2001 - ALPHARADIN
Première marque 2001 - ALPHARADIN

Industrie (Classification de Nice)

Derniers inventions, produits et services

2014 Invention Receptor binding conjugates. The present invention relates to a receptor binding conjugate which...
Invention Method of radiotherapy. The invention provides a method for the treatment of soft tissue disease...
2013 Invention Radio-pharmaceutical complexes. A tissue-targeting complex comprising a tissue targeting moiety,...
Invention Radio-pharmaceutical complexes. A tissue-targeting complex comprising a tissue targeting moiety, ...
2012 Invention Liquid container. The present invention relates to a container for liquids, a method of filling i...
Invention Pharmaceutical preparation comprising alpha emitting radionuclide. A pharmaceutical preparation c...
2011 Invention Isotope production method. 227Th by flowing a third mineral acid in a third aqueous solution thro...
Invention Isotope preparation method. The present invention provides a method for the generation of 223Ra o...
Invention Isotope production method. The present invention relates to a method for the generation of 223Ra ...
Invention Isotope preparation method. The present invention relates to a method for the generation of 223Ra...
Invention Targeted alpha- particle emitting complexes comprising thorium radionuclide hydroxypyridinone con...
Invention Targeted alpha-particle emitting complexes comprising 227-thorium radionuclide and hydroxypyridin...
2006 Invention Radiotherapy. The invention provides a method of radiation treatment of a human or non-human mamm...
2005 Invention Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy. The present in...
Invention Cytotoxic formulation for combination therapy.
The present invention relates to cytoto...
Invention Alpha-emitting hydroxyapatite particles. The present invention provides Hydroxyapatite (HA) incor...
Invention Alpha-emitting hydroxyapatite particles.
The present invention provides Hydroxyapatite...
2004 Invention Thorium-227 for use in radiotherapy of soft tissue disease. The invention provides a method for ...
Invention Thorium-227 for use in radiotherapy of soft tissue disease.
The invention provides a m...
Invention Receptor binding conjugates. The present invention relates to a receptor binding conjugate which ...
2003 Invention Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer th...
Invention Method of prophylaxis. A method of prophylaxis of a subject having or having had a soft tissue ca...
Invention Method of radiotherapy. The invention provides a method for the treatment of soft tissue disease ...
2001 P/S Pharmaceutical and veterinary preparations, namely, preparations for the treatment of cancer.
Invention Radioactive therapeutic liposomes. The present invention relates to a conjugator system comprisin...